Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danusertib in t(4;14) Multiple Myeloma
NCT00872300Phase 2Terminated
- Sponsor
- Nerviano Medical Sciences
- Start
- Oct 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of danusertib in multiple myeloma (MM), sponsored by Nerviano Medical Sciences. Started Oct 2008; status: terminated.
02
Drugs
danusertib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00872300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872300.